Randomization was well-executed, reinforcing the trials methodological rigor
P=.003) with combination therapy
For other GLP-1 RAs, the pattern seemed more like a linear increase with the dosage (liraglutide, semaglutide FE)
during hospitalisation, surgery or acute illness), in underweight people or when the diagnosis of type 1 diabetes is suspected
The short version Retatrutide is an investigational weight-loss and diabetes drug that works by activating three hormone receptors at the same time GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and glucagon
Participants were assigned to either moderate-intensity continuous exercise (1 hour of cycling at 50% maximal aerobic power) or sprint interval exercise (six 30-second all-out cycling sprints)